A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO)

Rice, 1999, Curr. Opin. Drug Discov. Devel., 2, 463 Sturzebecher, 1992, Biol. Chem. Hoppe-Seyler, 373, 1025, 10.1515/bchm3.1992.373.2.1025 Caughey, 1993, J. Pharmacol. Exp. Ther., 264, 676 Clark, 1995, Am. J. Respir. Crit. Care Med., 152, 2076, 10.1164/ajrccm.152.6.8520778 Clark, 1996, Drugs Future, 21, 811, 10.1358/dof.1996.021.08.375541 Pereira, 1998, Nature (London), 392, 306, 10.1038/32703 Ono, 1999, Bioorg. Med. Chem. Lett., 9, 3285, 10.1016/S0960-894X(99)00594-6 Steinmetzer, 1999, Eur. J. Biochem., 265, 598, 10.1046/j.1432-1327.1999.00742.x Rice, 2000, Bioorg. Med. Chem. Lett., 10, 2357, 10.1016/S0960-894X(00)00484-4 Rice, 2000, Bioorg. Med. Chem. Lett., 10, 2361, 10.1016/S0960-894X(00)00485-6 Slusarchyk, 2002, Bioorg. Med. Chem. Lett., 12, 3235, 10.1016/S0960-894X(02)00689-3 Sutton, 2004, Bioorg. Med. Chem. Lett., 14, 2233, 10.1016/j.bmcl.2004.02.012 Zhao, 2004, Bioorg. Med. Chem. Lett., 14, 309, 10.1016/j.bmcl.2003.11.016 Palmer, 2006, Bioorg. Med. Chem. Lett., 16, 3434, 10.1016/j.bmcl.2006.04.013 Lee, 2006, Bioorg. Med. Chem. Lett., 16, 4036, 10.1016/j.bmcl.2006.05.009 Levell, 2005, Bioorg. Med. Chem. Lett., 13, 2859, 10.1016/j.bmc.2005.02.014 Hopkins, 2004, Bioorg. Med. Chem. Lett., 14, 4819, 10.1016/j.bmcl.2004.07.051 Hopkins Corey, 2005, Bioorg. Med. Chem. Lett., 15, 2734, 10.1016/j.bmcl.2005.04.002 Costanzo Michael, 2008, Bioorg. Med. Chem. Lett., 18, 2114, 10.1016/j.bmcl.2008.01.093 Vaz, 2004, Bioorg. Med. Chem. Lett., 14, 6053, 10.1016/j.bmcl.2004.09.065 Sommerhoff, 1999, Proc. Natl. Acad. Sci. U.S.A., 96, 10984, 10.1073/pnas.96.20.10984 Sommerhoff, 2000, Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol., 1477, 75, 10.1016/S0167-4838(99)00265-4 Airenne, 2005, Protein Sci., 14, 1964, 10.1110/ps.051438105 Jakobsson, 1550, Acta Crystallogr. D: Biol. Crystallogr., 2005, D61